Posts

STAT+: Amgen’s rheumatoid arthritis drug Enbrel targete...

Colorado moves to cap the price of Etanercept, an autoimmune drug sold by Amgen ...

STAT+: UnitedHealth cyberattack impedes pharmacies’ and...

Hospitals and pharmacies are stuck in an insurance processing logjam after a cyb...

Neurobiology: How bats distinguish different sounds

FRANKFURT. Seba’s short-tailed bat (Carollia perspicillata) lives in the subtrop...

Innovative chemotherapy approach shows promise against ...

Lung cancer is not the most common form of cancer, but it is by far the deadlies...

Shaping the future: A new technique for sorting micro-p...

Thanks to the rapid progress in tiny tech, we’ve been mainly using microfluidics...

Encoding computers of the future

In our data-driven era, solving complex problems efficiently is crucial. However...

Sir Peter Rigby appointed as honorary chair of Aston Un...

Aston University is delighted to announce that it has appointed one of the UK’s ...

Dual-energy harvesting device could power future wirele...

UNIVERSITY PARK, Pa. — Implantable biomedical devices — like pacemakers, insulin...

Aston University receives nearly half a million pounds ...

•    Researchers to explore the use of gel electrolyte materials to improve lith...

Cloud clustering causes more extreme rain

Understanding cloud patterns in our changing climate is essential to making accu...

Scientists closer to solving mysteries of universe afte...

Scientists are a step closer to unravelling the mysterious forces of the univers...

Down Under Demo: ONR touts additive manufacturing tech ...

ARLINGTON, Va.—The Office of Naval Research (ONR) — and its international arm, O...

Unlocking health: How In Our DNA SC is pioneering genet...

Physicians and scientists have known for many years that our genetics not only s...

NJIT marketing experts measure brain waves and skin cur...

Machines still can’t think, but now they can validate your feelings, based on ne...

A very long, winding road: Developing novel therapeutic...

“Given that the MET inhibitor capmatinib caused a remarkable response in Dr. Bla...

MHRA revokes Novartis’ Adakveo authorisation for sickle...

The UK MHRA has revoked a conditional marketing authorisation for Novartis' Adak...